Definitive Contract 75F40122C00169

Award Date 9/27/22
Potential Completion Date 12/31/24
Potential Value $624K
Ultimate Awardee
University Of Tennessee
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Memphis, TN 38103, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
165
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $503,739 definitive cost-no-fee contract to the University of Tennessee to conduct research on the evaluation of small animal models for COVID-19 and their application in nonclinical safety and efficacy studies of investigational therapeutics. This contract is not associated with a set-aside program. As a major public research institution and land-grant university, the University of Tennessee has extensive expertise in medical research,...
This is a $24,919 firm-fixed price purchase order contract awarded by the U.S. Food and Drug Administration (FDA) to the University of Tennessee to develop standard operating procedures (SOPs) to ensure viral inactivation in various maternal and fetal tissue samples and blood prior to shipment to the FDA's National Center for Toxicological Research (NCTR). The contract has no set-aside designation and was awarded on July 8, 2021, with a completion date of July 7, 2022. The University of...
This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health to the University of Tennessee, a public land grant university, on September 15, 1999. The contract does not have a set-aside designation and has a potential value of $4,003,082.00. The University of Tennessee has substantial experience as a prime contractor and subcontractor, providing analytical and consulting services to the Department of Defense as well as conducting research...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to the University of Tennessee, operating as the Univ Tennessee System Office. The contract, valued at $9,498,336.00, is for biomedical research and exploration activities. No set-aside designation was used for this definitive contract, which has a cost-no-fee pricing type. The University of Tennessee has extensive experience conducting scientific research and providing analytical services...
This is a federal contract award from the Department of Defense's Bureau of Medicine and Surgery to the University of Tennessee, a major public land-grant research university system. The contract is for $127,812.00 and has an ultimate completion date of December 31, 2015. The contract is for tuition and fees, and is a firm fixed-price delivery order. No set-aside designation was used. The University of Tennessee has extensive experience conducting research, analysis, and educational...
The University of Tennessee was awarded a $1,129,039 federal contract from the U.S. Army Corps of Engineers Humphreys Engineer Center Support Activity to conduct research on the microbial attenuation of polyfluoroalkyl substances (PFAS). This definitive cost-type contract runs through April 2029 and is part of the Department of Defense's Strategic Environmental Research and Development Program (SERDP), which funds environmental research and development projects. The University of Tennessee is...
This is a firm fixed-price delivery order contract awarded by the Department of Defense's Bureau of Medicine and Surgery to the University of Tennessee for tuition and fees, with a ceiling value of $77,862.00 and a completion date of June 30, 2023. The contract does not have a set-aside designation. The University of Tennessee is the prime contractor and is a major public land-grant research university system that provides a wide range of educational, research, and public service activities to...
This federal contract award was issued by the National Heart Lung and Blood Institute, a civilian agency under the U.S. Department of Health and Human Services, to the University of Tennessee, operating as the Univ Tennessee System Office. The $112,437,576.00 Definitive Contract is for BIOMEDICAL (APPLIED/EXPLORATORY) work, with a performance period ending on June 5, 2014. The contract has a Cost No Fee pricing type and was not set aside for any specific business category. The University of...
The University of Tennessee, Knoxville is providing research services as the prime contractor on a $266,332 cost-no-fee contract from the Department of Homeland Security Science and Technology Directorate. The contract is for the period of September 30, 2015 through July 31, 2019 to support the development of a rapid, low-cost, field-deployable diagnostic device for viral infectious diseases in animals, as described in the original solicitation. No set-aside designation was specified for this...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to the University of Tennessee, operating as the Univ Tennessee System Office, for TUITION AND FEES. The $95,292.00 firm fixed-price delivery order does not have a set-aside designation. The University of Tennessee is a public land-grant research university system that frequently serves as both a prime contractor and subcontractor on various federal projects, leveraging...

The University of Tennessee, doing business as Finance and Operation, was awarded a $623,991 Cost No Fee contract from the Food and Drug Administration (FDA) to conduct a longitudinal quantitative evaluation of the clinical, immunological, and virological characteristics of COVID-19 in mucosal, blood, and fecal specimens from adults, children, and exposed household members. This contract is not set aside. The University of Tennessee is a major public research institution and land-grant university that receives substantial federal funding for research and development activities across a wide range of areas, including healthcare, biomedical sciences, engineering, agriculture, and education. The university has an Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases valued at $146.3 million for the development and use of animal and animal replacement models to evaluate medical countermeasures against infectious diseases.

Generated 9/17/24, 9:09 AM